The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world examination of remission patterns in patients (pts) with acute myeloid leukemia (AML).
 
Ashley Tabah
Employment - Celgene/Bristol-Myers Squibb
Stock and Other Ownership Interests - Celgene/Bristol-Myers Squibb
Honoraria - Abbvie (I); Amgen (I); Celgene/Bristol-Myers Squibb (I); Janssen (I); Roche (I)
Consulting or Advisory Role - Abbvie (I); Janssen (I)
Travel, Accommodations, Expenses - Celgene/Bristol-Myers Squibb (I); Janssen (I); Roche (I)
 
David Huggar
Employment - Celgene/Bristol-Myers Squibb
Stock and Other Ownership Interests - Amarin Corporation; Bristol-Myers Squibb; CareDX; Celgene
Research Funding - Celgene/Bristol-Myers Squibb
 
Brenna L. Brady
Employment - IBM
 
Krutika Jariwala-Parikh
Employment - IBM
Research Funding - Celgene/Bristol-Myers Squibb (Inst)
 
Ronda Copher
Employment - Celgene/Bristol-Myers Squibb
Stock and Other Ownership Interests - Celgene/Bristol-Myers Squibb
Research Funding - Celgene/Bristol-Myers Squibb
 
Thomas William LeBlanc
Honoraria - Celgene; Daiichi Sankyo; Quintiles
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Heron; Otsuka; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Amgen; Celgene; Daiichi Sankyo; Heron; Otsuka